Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

Clinical trial NCT04940065 · COMPLETED

Trial details

NCT number: NCT04940065
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing-remitting Multiple Sclerosis Active Secondary Progressive Multiple Sclerosis

Start date: 2021-06-30
Primary completion: 2024-12-12
Enrollment: 367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.